Site Management Organization in TX & LA Secures Participation in AZD1222 COVID-19 Clinical Trial

Site Management Organization in TX & LA Secures Participation in AZD1222 COVID-19 Clinical Trial

Centex Studies-Lake Charles recently announced that the clinical investigational site in Lake Charles, Louisiana was selected by AstraZeneca for their Phase 2/3 clinical trial commencing in Mid-August. This clinical trial evaluates the safety and efficacy of AZD1222, one of the most promising of COVID-19 vaccines that was developed at University of Oxford, Jenner Institute. AstraZeneca reports that a single-dose of AZD1222 has triggered a four-fold increase in SARS-CoV-2 antibodies in 95% of those individuals vaccinated.

The Vaccine

TrialSite can confidently report that AZD1222 represents one of the leading contenders among the investigational COVID-19 vaccines. As reported recently by KATC in Louisiana, the vaccine “uses a replication-deficient chimpanzee viral vector based on a weakened version of a common cold virus (adenovirus) that causes infections in chimpanzees and contains the genetic material of the SARS-CoV-2 virus spike protein.” With hope, the human immune system will be charged and ready to combat COVID-19, should it infect the body.

Who is Centex Studies?

Centex Studies is a site management organization with locations in Houston and McAllen Texas as well...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee